What's breaking now, across thousands of outlets.
Merck detailed some mid-stage data in a debilitating skin condition on Wednesday morning for the centerpiece of its $10.8 billion Prometheus Biosciences acquisition. Both the middle and high doses of tulisokibart achieved a statistically significant ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
A young Westmeath woman diagnosed with stage four bowel cancer earlier this year is urging others and in particular women to trust their instincts, if they feel something is wrong.
The pandemic was the worst thing that could have happened to the Big Four giants and the overall consultancy market. At the time, these firms were flying high, flooded with inquiries from businesses…
A force should have flagged mental health services after a family called about their son, IOPC says.
(RTTNews) - Mayne Pharma Group Limited (MYX.AX) has reached settlement with Sun Pharmaceutical Industries Ltd. (SUNPHARMA.NS), resolving the Paragraph 1V patent litigation concerning IMVEXXY…
[Daily Trust] Former Vice President and ADC presidential candidate Atiku Abubakar has demanded the immediate publication of Nigeria's health agreement with the United States, following President John…
New three-year ARCADIA long-term extension data demonstrate that Nemluvio is well-tolerated and associated with sustained and continuous improvements in skin lesions, itch, sleep disturbance and…
